Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study (Q28290823)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q42574214)
(P304) 796-804
(P407) (Q1860)
(P433) 9
(P478) 7
(P577) +2008-09-00T00:00:00Z
(P921) (Q269829)
(Q18555066)
(Q8277)
(Q181600)
(Q79460)
(P1433) (Q15755067)
(P1476) "Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study" (language: en)
(P2093) Benjamin M Segal
Aparna Raychaudhuri
Lilianne Kim
Rosanne Fidelus-Gort
Lloyd H Kasper
(P2860) (Q40437100)
(Q48414534)
(Q36963184)
(Q57912405)
(Q48176144)
(Q28293763)
(Q28255548)
(Q29614225)
(Q29547525)
(Q36400329)
(Q36367147)
(Q24290619)
(Q71610356)
(Q28266133)
(Q36365596)
(Q48412662)
(Q35957193)
(Q24338636)
(Q48442189)
(Q38363544)
(Q29620481)
(Q72427037)
(Q34575334)
(Q79755041)
(Q73197820)
(Q82263194)
(Q40796002)
(Q81245834)
(Q80250281)
(Q22252943)
(Q22241644)
(Q40810823)
(Q30640097)
(Q30573085)
(Q93569390)
(Q28280453)
(Q28280465)
(Q36259695)
(Q34472062)
(Q79718082)
(Q28284231)
(Q54270046)
(Q34411828)
(Q36368672)
(Q34651378)
(Q48200750)
(Q28268626)
other details
description scientific article

External Links